Delivery Order SPE2DB24D2205-SPE2DB24FDWQE

Award Date 7/10/24
Potential Completion Date 7/11/24
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $1,100.38, is for the delivery of Viberzi 75 mg tablet 60s to the Defense Logistics Agency (DLA). The award is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,138.42 firm-fixed-price delivery order is for the pharmaceutical product VIBERZI 75 MG TABLET 60S. The contract has an ultimate completion date of June 25, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,185.81 Firm Fixed Price delivery order is for the supply of 4,566,760,296 units of the medication Viberzi 100 mg tablet. The award has an ultimate completion date of December 19, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price Delivery Order contract worth $1,743.80 to provide VIBERZI 100 MG TABLET 60S. The contract has a completion date of March 1, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a performance period through...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is a Delivery Order (DO) issued under a Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The DO, valued at $1,226.11, is for the supply of VIBERZI 100 MG TABLET 60S, a pharmaceutical product. The contract has a completion date of March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the contract does not have a set-aside...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of Viberzi 100 mg tablets for the Defense Logistics Agency (DLA). The $2,222.21 firm fixed-price delivery order has a completion date of February 21, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price of $2,221.58 for the delivery of 60 tablets of the medication Viberzi 75 mg. The contract has an ultimate completion date of June 24, 2025 and was awarded on June 23, 2025. The contract is not set aside and is open to competition. Amerisourcebergen Drug Corp is...
This federal contract award, valued at $3,472.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract to supply 4,568,038,385 units of the pharmaceutical product Viberzi 75 mg tablets. The contract has an ultimate completion date of April 28, 2025 and is a firm fixed-price arrangement. It is not designated as a set-aside contract, indicating open...
This federal contract award is for the pharmaceutical product Viberzi 100 mg tablet, 60 count, with a firm fixed price of $1,343.66 and an ultimate completion date of October 18, 2024. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. This is a delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,576.69 firm fixed-price delivery order is for the medication Viberzi 100 mg Tablet 60s, with a performance period ending on May 5, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDWQE
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of Viberzi 100mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $1,686.83, is a Firm Fixed Price Delivery Order with a completion date of July 11, 2024. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. government, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range of medical commodities to military treatment programs and facilities globally. The contract does not have a set-aside designation.

Generated 10/9/24, 9:21 AM